About Soterius
Soterius is a company based in Princeton (United States) founded in 2018 by Suneet Walia. It operates as a Managed Services and HealthTech. Soterius has raised $1.5 million across 1 funding round from investors including Celegence. The company has 41 employees. Soterius offers products and services including Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITYâ„¢dx Platform. Soterius operates in a competitive market with competitors including SFL Regulatory Affairs & Scientific Communication, Scinopsis, InfocusRx, Regulatory Professionals and AxPharma, among others.
- Headquarter Princeton, United States
- Employees 41
- Founders Suneet Walia
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website soterius.com
- Social LinkedIn X Facebook YouTube
- Legal Name Soterius Life Sciences India Private Limited
- Date of Incorporation 26 Dec, 2018
- Jurisdiction Delhi, India
- Annual Revenue₹9.61 Cr
FY 2025 · +17% YoY
- Net Profit₹62.6 Lakh
FY 2025 · 7% margin
- EBITDA₹94.1 Lakh
FY 2025 · 10% margin
- Total Equity Funding$1.5M (USD)
in 1 rounds
- Latest Funding Round$1.5M (USD), Series A
Mar 2020
- Investors
- Employee Count41
Associated legal entities of Soterius
Soterius operates through Soterius Life Sciences India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Soterius Life Sciences India Private Limited CIN U74999DL2018FTC343480 | Active | 26 Dec 2018 | Delhi, Delhi | ₹9.6 Cr | 41 | 3 | View details |
Products & Services of Soterius
Soterius offers a comprehensive portfolio of products and services, including Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITY™dx Platform.
Clinical safety services are provided for drug monitoring.
Postmarket drug safety monitoring services are offered globally.
Medical information and writing support are delivered internationally.
Technology platform for drug safety is developed innovatively.
Apps and channels of Soterius
its YouTube channel Soterius has 23 subscribers and 3 videos.
Videos from Soterius
The most watched videos on Soterius's YouTube channel, Soterius (23 subscribers). Click a video to play it here.
More on Soterius.
Funding Insights of Soterius
Soterius has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.5 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 1
- Last Round Series A — $1.5M
- First Round $1.5M
(Mar 2020)
- Investors Count 1
All 1 funding rounds of Soterius with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2020 | $1.5M | Series A | – | Celegence | – |
1 investors in total: 1 institutional.
Investors in Soterius
Soterius has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Celegence.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance. | 2017 | celegence.com | Downers Grove, United States |
Investor details for Soterius
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Soterius Life Sciences India Private Limited (Soterius)
Soterius Life Sciences India Private Limited is the primary company behind Soterius. The board of Soterius Life Sciences India Private Limited currently have 3 directors; the longest-serving is Suneet Walia, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suneet Walia DIN 08313350 | Director | 26 Dec 2018 | 7 yrs 9 mo | Soterius Life Sciences India Private Limited |
| Sumit Verma DIN 07945308 | Whole-time director | 26 Dec 2018 | 7 yrs 9 mo | Soterius Life Sciences India Private Limited |
| Neeraj Aggarwal DIN 06720121 | Director | 28 Mar 2019 | 7 yrs 6 mo | Soterius Life Sciences India Private Limited |
People of Soterius
24 people are tracked at Soterius (6 in leadership, 6 in board & advisors, 12 in team); the tracked headcount is 41.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership | |
Bhumi Vyas | Head, Corporate Quality Assurance | Leadership |
Parul Singla | Senior Director, Clinical Safety & Pharmacovigilance | Leadership |
Neeru Bakshi | Head, Computer System Validation | Leadership |
Dr. Sumit Verma | President – Operations And Director | Leadership |
Howard Abroms | VP Global Business Development | Leadership |
Rakesh Dighe | Board Member | Board & advisors |
Bharti Khanna | Advisor | Board & advisors |
Hal Ward | Advisor | Board & advisors |
Arun Purohit | Advisor | Board & advisors |
Suneel Gupta | Advisor | Board & advisors |
Sonia Veluchamy | Board Member | Board & advisors |
Tanvi Chaturvedi | Senior Manager, Clinical Safety & Pharmacovigilance | Team |
Mani Agnihotri | Senior Associate - Clinical Safety And Pharmacovigilance | Team |
| SVP, Safety Operations | Team | |
Yogesh Gulati | Subject Matter Expert, Clinical Safety & Pharmacovigilance | Team |
Dr. Yogesh Gulati | Senior Safety Physician | Team |
Rajat G. | Business Development Associate | Team |
Prateek Singhal | Senior Pharmacovigilance Associate | Team |
Shivani Mohan | Assistant Manager | Team |
4 more people are available in the full profile.
Complete people profiles for Soterius
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Soterius
Figures of Soterius Life Sciences India Private Limited, the primary company behind Soterius, for FY 2025. Revenue was ₹9.61 Cr (+17% year on year). Net profit was ₹62.6 Lakh (7% margin). EBITDA was ₹94.1 Lakh (10% margin). Revenue has grown at a compounded annual rate of +23% over three years and +46% over five years.
- ₹9.61 CrRevenue · FY 2025 · +17% YoY
- ₹62.6 LakhNet profit · 7% margin
- ₹94.1 LakhEBITDA · 10% margin
- ₹45 LakhPaid-up capital
- 41Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +46%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Soterius Life Sciences India Private Limited are on its company page.
Detailed financial statements for Soterius
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Soterius
2 dated milestones of Soterius across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Soterius is founded.
- Funding First funding round of $1.5M.
Competitors of Soterius
Soterius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SFL Regulatory Affairs & Scientific Communication, Scinopsis, InfocusRx, Regulatory Professionals and AxPharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sfl-services.com | 2009 | Basel, Switzerland | – | – | Consulting services in regulatory affairs and scientific communication are provided. | |
| scinopsis.com | 2006 | Frejus, France | – | – | Semiconductor and power electronic devices are manufactured for various sectors. | |
| infocusrx.com | 2008 | Hyderabad, India | – | 9 | Offers branding, digital marketing, and knowledge services for healthcare industries. | |
| regprofessional.com | 1995 | Newark, United States | – | – | Regulatory consulting services for medical writing and strategies are provided. | |
| axpharma.com | 2001 | Paris, France | – | – | Provider of vigilance, case treatment, and medical writing services for life science companies | |
| sclintech.com | 2015 | Secunderabad, India | – | – | Delivers clinical trial data management and medical writing services for the biopharma industry. | |
| tpireg.com | 2013 | Oakville, Canada | – | – | Regulatory consulting services are offered for therapeutic product support. |
Detailed competitors of Soterius
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Soterius
The website of Soterius (soterius.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▼ 13.8% vs previous month
Latest news on Soterius
Complete news archive for Soterius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Soterius
10 companies that operate in the same segment as Soterius (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Soterius
Soterius was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Soterius is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Suneet Walia is the current CEO of Soterius. They have also founded this company.
Soterius is a funded company, having raised a total of $1.5M across 1 funding round to date. The company's 1st funding round was a Series A of $1.5M, raised on Mar 2020.
Soterius has 41 employees.
The primary company behind Soterius, Soterius Life Sciences India Private Limited, reported revenue of ₹9.61 Cr for FY 2025, up 17% year on year.
Soterius is involved in providing pharmacovigilance, clinical safety, and medical affairs services to the pharmaceutical industry. Solutions are offered across multiple geographies, supporting regulatory compliance and drug safety through innovative technology platforms like UNITYdx. Services include clinical SAE processing, medical literature monitoring, and risk management plans. The company operates in the healthcare sector, focusing on enhancing data transparency and compliance for global and local pharmaceutical clients.
Soterius's top competitors include Regulatory Professionals, SFL Regulatory Affairs & Scientific Communication and Therapeutic Products.
Soterius offers Clinical Safety Services, Postmarketed Pharmacovigilance Services, Medical Affairs and Writing, and UNITYâ„¢dx Platform.
Soterius has 1 investor. Key investors include Celegence.
Soterius operates through Soterius Life Sciences India Private Limited.
The legal entities of Soterius currently have 3 directors, including Suneet Walia, Sumit Verma, Neeraj Aggarwal.